Ligand validation:1V3D

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 1V3D designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
1V3D_NAG_B_5231	33%	68%	0.194	0.875	0.57	0.67	-	-	0	0	100%	1
1V3D_NAG_B_3081	13%	67%	0.259	0.803	0.64	0.62	-	-	0	0	100%	1
1V3D_NAG_A_5231	10%	59%	0.236	0.737	0.7	0.86	-	1	2	0	100%	1
1V3D_NAG_A_3081	4%	68%	0.31	0.686	0.62	0.62	-	-	2	0	100%	1
4WEF_NAG_B_602	56%	47%	0.14	0.91	0.49	1.52	-	4	0	0	100%	1
4MZA_NAG_A_611	47%	56%	0.105	0.842	0.48	1.19	-	2	0	0	100%	1
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	1
9OAR_NAG_C_202	100%	55%	0.021	0.994	0.68	1.06	-	1	0	0	100%	1
5U7O_NAG_B_704	100%	88%	0.024	0.989	0.23	0.44	-	-	0	0	100%	1
5JFI_NAG_A_703	100%	53%	0.026	0.995	0.91	0.89	2	1	0	0	100%	1
2C11_NAG_A_1734	100%	66%	0.027	0.989	0.67	0.63	-	-	4	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.